Lupus Science & Medicine: 10 (1)

Brief communication

Genetic load in incomplete lupus erythematosus (4 January, 2023)
Matt Slief, Joseph M Kheir, Miles Smith, Colin Mowery, Susan Macwana, Wade DeJager, Catriona A Wagner, Teresa Aberle, Judith A James, Joel M Guthridge

Co-morbidities

Original research: Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE (3 March, 2023)
Stylianos Panopoulos, George C Drosos, George Konstantonis, Petros P Sfikakis, Maria G Tektonidou
Original research: Clinical associations of cognitive dysfunction in systemic lupus erythematosus (28 February, 2023)
Sudha Raghunath, Yifat Glikmann-Johnston, Vera Golder, Rangi Kandane-Rathnayake, Eric F Morand, Julie C Stout, Alberta Hoi
Original research: Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus (14 February, 2023)
Sebastian Bruera, Xiudong Lei, Hui Zhao, Jinoos Yazdany, Mariana Chavez-MacGregor, Sharon H Giordano, Maria E Suarez-Almazor

Cutaneous lupus

Original research: Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China (20 March, 2023)
Hui Jin, Shihang Zhou, Yangyiyi Yu, Ming Zhao, Haijing Wu, Hai Long, Siqi Fu, Ruifang Wu, Heng Yin, Jieyue Liao, Shuangyan Luo, Yu Liu, Qing Zhang, Peng Zhang, Yixin Tan, Shuaihantian Luo, Xin Huang, Fen Li, Guanghui Ling, Qianjin Lu

Epidemiology and outcomes

Original research: A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort (14 February, 2023)
Manuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Mariela Medina, Claudia Elera-Fitzcarrald, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Risto Alfredo Perich-Campos, Graciela S Alarcón
Original research: Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study (3 February, 2023)
Rory C Monahan, Liesbeth J J Beaart-van de Voorde, Rolf Fronczek, Jeroen de Bresser, Jeroen Eikenboom, Margreet Kloppenburg, Huub A M Middelkoop, Gisela M Terwindt, Nic J A van der Wee, Tom W J Huizinga, Gerda M Steup-Beekman

Immunology and inflammation

Original research: Molecular endotypes of type 1 and type 2 SLE (30 January, 2023)
Robert Robl, Amanda Eudy, Prathyusha S Bachali, Jennifer L Rogers, Megan Clowse, David Pisetsky, Peter Lipsky
Original research: Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus (11 January, 2023)
Serena Fasano, Valentina Messiniti, Michele Iudici, Melania Alessia Coscia, Francesco Ciccia

Letter

Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE – 18 months later (25 January, 2023)
Alain Cornet, Jeanette Andersen, Chiara Tani, Marta Mosca

Lupus nephritis

Original research: Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis (30 January, 2023)
Ahmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, Alton B Farris, Jason Cobb, Monica Battle, David Chain, Jennifer A Cann, Gábor G Illei, S Sam Lim, Wendy I White
Original research: Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials (13 January, 2023)
Ian N Bruce, Ronald F van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala

Meeting report

Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective (14 February, 2023)
Joy Buie, Lauren Bloch, Eric F Morand, Ronald F van Vollenhoven, Victoria P Werth, Zahi Touma, Peter Lipsky, Kenneth Kalunian, Anca D Askanase, L Ines, Christopher Reed, MaryBeth Son, Timothy Franson, Karen Costenbader, Laura Eve Schanberg
Lupus spectrum ambiguity has long-term negative implications for patients (11 January, 2023)
Ian N Bruce, Joy Buie, Lauren Bloch, Sang-Cheol Bae, Karen Costenbader, Roger A Levy, Victoria P Werth, Ashley Marion, Sanjyot Sangodkar, Susan Manzi

Review

Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives (22 February, 2023)
Eya Toumi, Soraya Mezouar, Anne Plauzolles, Laurent Chiche, Nathalie Bardin, Philippe Halfon, Jean Louis Mege

Short report

Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data (24 March, 2023)
David D'Cruz, Gina Eriksson, Yulia Green, Anne Hammer, Beulah Ji, Paige Meizlik, David A Roth
Pacritinib abrogates the lupus phenotype in ABIN1[D485N] mice (23 February, 2023)
Tsvetana Petrova, Clara Figueras-Vadillo, Sambit K Nanda, Cheryl Scudamore, Philip Cohen

Main menu

Current Issue

2023 - Volume 10 - 1

Brief communication

Co-morbidities

Cutaneous lupus

Epidemiology and outcomes

Immunology and inflammation

Letter

Lupus nephritis

Meeting report

Review

Short report

Log in using your username and password

Main menu

Log in using your username and password

You are here

Current Issue

2023 - Volume 10 - 1

Brief communication

Co-morbidities

Cutaneous lupus

Epidemiology and outcomes

Immunology and inflammation

Letter

Lupus nephritis

Meeting report

Review

Short report